A multicentre randomized, double-blind, placebo-controlled Phase 2a study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult patients with Chronic Diabetic Peripheral Neuropathic Pain..

Project: Research

Status	Active
Effective start/end date	08/22/23 → 02/1/27

Project Details